Bayh-Dole
Biden Plans to Enact Trump Rule Allowing Drug Companies to Price Gouge on Life-Saving Treatments
Summary
The plan, initiated by the Trump administration in January, would gut a key government power for making sure taxpayer-funded pharmaceuticals are available to the public at reasonable prices.
Enter your email to keep reading
It’s free. You’ll also get emails about our latest reporting. Unsubscribe anytime.
Continue reading
Already have an account? Sign in
